US38170A
(en)
|
|
1863-04-14 |
|
Improvement in lamps |
US5294533A
(en)
|
1988-07-05 |
1994-03-15 |
Baylor College Of Medicine |
Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
|
US5135917A
(en)
|
1990-07-12 |
1992-08-04 |
Nova Pharmaceutical Corporation |
Interleukin receptor expression inhibiting antisense oligonucleotides
|
US5271941A
(en)
|
1990-11-02 |
1993-12-21 |
Cho Chung Yoon S |
Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases
|
US5786138A
(en)
|
1993-01-29 |
1998-07-28 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Hyperstabilizing antisense nucleic acid binding agents
|
EP0703979B1
(fr)
|
1993-06-04 |
2000-09-13 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Methode de traitement du sarcome de kaposi par des oligonucleides antisens
|
US5578716A
(en)
|
1993-12-01 |
1996-11-26 |
Mcgill University |
DNA methyltransferase antisense oligonucleotides
|
US5641754A
(en)
|
1994-01-10 |
1997-06-24 |
The Board Of Regents Of The University Of Nebraska |
Antisense oligonucleotide compositions for selectively killing cancer cells
|
US5624813A
(en)
|
1994-04-21 |
1997-04-29 |
Mahant; Vijay K. |
NAD(P)+ /NAD(P)H based chemiluminescent diagnostics
|
JPH10503934A
(ja)
|
1994-08-09 |
1998-04-14 |
ノバルティス アクチエンゲゼルシャフト |
抗腫瘍性アンチセンスオリゴヌクレオチド
|
US5856103A
(en)
|
1994-10-07 |
1999-01-05 |
Board Of Regents The University Of Texas |
Method for selectively ranking sequences for antisense targeting
|
US5994320A
(en)
|
1995-02-06 |
1999-11-30 |
Regents Of The University Of Minnesota |
Antisense oligonucleotides and methods for treating central nervous system tumors
|
IT1275862B1
(it)
|
1995-03-03 |
1997-10-24 |
Consiglio Nazionale Ricerche |
Trascritto antisenso associato ad alcuni tipi di cellule tumorali ed oligodeossinucleotidi sintetici utili nella diagnosi e nel trattamento
|
US6040296A
(en)
|
1995-06-07 |
2000-03-21 |
East Carolina University |
Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
|
FR2739029B1
(fr)
|
1995-09-21 |
1997-11-21 |
Roussel Uclaf |
Nouvelle application therapeutique des composes antimineralo-corticoides
|
AU7286696A
(en)
|
1995-10-13 |
1997-05-07 |
F. Hoffmann-La Roche Ag |
Antisense oligomers
|
KR19990071523A
(ko)
|
1995-11-21 |
1999-09-27 |
해리 에이. 루스제 |
Il-8 및 il-8 수용체에 대한 안티센스올리고누클레오티드에 의한 종양 성장의 억제방법
|
AU1067697A
(en)
|
1995-12-05 |
1997-06-27 |
Jouko Antero Oikarinen |
Hsd17b1 promoter, enhancer, silencer and use thereof
|
US5998602A
(en)
|
1996-02-15 |
1999-12-07 |
The Cleveland Clinic Fouindation And Government |
RNase L activators and antisense oligonucleotides effective to treat RSV infections
|
US5955590A
(en)
|
1996-07-15 |
1999-09-21 |
Worcester Foundation For Biomedical Research |
Conjugates of minor groove DNA binders with antisense oligonucleotides
|
US6046004A
(en)
|
1997-02-27 |
2000-04-04 |
Lorne Park Research, Inc. |
Solution hybridization of nucleic acids with antisense probes having modified backbones
|
JPH1142091A
(ja)
|
1997-07-25 |
1999-02-16 |
Toagosei Co Ltd |
アンチセンス核酸化合物
|
US6391311B1
(en)
|
1998-03-17 |
2002-05-21 |
Genentech, Inc. |
Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
|
US6046319A
(en)
|
1997-10-22 |
2000-04-04 |
University Technologies International, Inc. |
Antisense oligodeoxynucleotides regulating expression of TNF-α
|
ES2312205T3
(es)
|
1998-03-10 |
2009-02-16 |
Genentech, Inc. |
Nuevo polipeptido y acidos nucleicos que lo codifican.
|
AU2707999A
(en)
|
1998-03-11 |
1999-09-27 |
Endorecherche Inc. |
Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and methods for their use
|
US6007995A
(en)
|
1998-06-26 |
1999-12-28 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of TNFR1 expression
|
US6013522A
(en)
|
1999-02-23 |
2000-01-11 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of human Smad1 expression
|
US6025198A
(en)
|
1999-06-25 |
2000-02-15 |
Isis Pharmaceuticals Inc. |
Antisense modulation of Ship-2 expression
|
US6033910A
(en)
|
1999-07-19 |
2000-03-07 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of MAP kinase kinase 6 expression
|
FR2801218B1
(fr)
|
1999-11-23 |
2001-12-28 |
Hoechst Marion Roussel Inc |
Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
|
US7754709B2
(en)
|
2003-06-10 |
2010-07-13 |
Solvay Pharmaceuticals Bv |
Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
|
US20050158376A1
(en)
|
2003-10-23 |
2005-07-21 |
Sardi William F. |
Dietary supplement and method of processing same
|
US20090169585A1
(en)
|
2003-10-23 |
2009-07-02 |
Resveratrol Partners, Llc |
Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
|
WO2005108415A2
(fr)
|
2004-04-30 |
2005-11-17 |
Biogen Idec Ma Inc. |
Molecules associees aux membranes
|
JP5236286B2
(ja)
|
2004-05-07 |
2013-07-17 |
セレラ コーポレーション |
肝線維症に関連する遺伝的多型、その検出方法および使用
|
FR2904000A1
(fr)
|
2006-07-19 |
2008-01-25 |
Galderma Res & Dev S N C Snc |
Modulateurs de hsd17b7 dans le traitement de l'acne ou de l'hyperseborrhee
|
US20100267052A1
(en)
|
2006-09-01 |
2010-10-21 |
American Type Culture Collection |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
US20090203602A1
(en)
|
2006-09-01 |
2009-08-13 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
US20080300170A1
(en)
|
2006-09-01 |
2008-12-04 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment for type 2 diabetes
|
WO2008091873A2
(fr)
|
2007-01-24 |
2008-07-31 |
Dana-Farber Cancer Institute, Inc. |
Compositions et procédés d'identification, d'évaluation, de prévention et de thérapie du cancer
|
JP2010540444A
(ja)
|
2007-09-20 |
2010-12-24 |
レスベラトロル パートナーズ, エルエルシー |
遺伝子産物の濃縮または活性を調節するためのレスベラトロールを含む組成物
|
WO2009148137A1
(fr)
|
2008-06-04 |
2009-12-10 |
協和発酵キリン株式会社 |
Acide nucléique capable de réguler la dégranulation d'un mastocyte
|
US20100056384A1
(en)
|
2008-09-04 |
2010-03-04 |
Board Of Regents, The University Of Texas System |
Sequence Variations in PNPLA3 Associated with Hepatic Steatosis
|
US20100209427A1
(en)
|
2008-09-24 |
2010-08-19 |
Yu Li |
Lysine acetylation sites
|
EP2177615A1
(fr)
|
2008-10-10 |
2010-04-21 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Procédé pour une identification large du génome de séquences régulatrices de l'expression et utilisation de gènes et de molécules dérivées pour le diagnostic et le traitement de maladies métaboliques et/ou tumorales
|
WO2010064702A1
(fr)
|
2008-12-05 |
2010-06-10 |
国立大学法人 東京大学 |
Biomarqueur pour prédire un pronostic de cancer
|
US20100266618A1
(en)
|
2009-03-18 |
2010-10-21 |
Children's Hospital Of Eastern Ontario Research Institute |
Compositions and methods for augmenting activity of oncolytic viruses
|
US20120028816A1
(en)
|
2009-03-31 |
2012-02-02 |
Warren Stephen T |
Methods and systems for screening for and diagnosing dna methylation associated with autism spectrum disorders
|
US9051567B2
(en)
|
2009-06-15 |
2015-06-09 |
Tekmira Pharmaceuticals Corporation |
Methods for increasing efficacy of lipid formulated siRNA
|
DK3329772T3
(da)
|
2009-07-15 |
2020-01-27 |
Calimmune Inc |
Dobbeltvektor til inhibering af human immundefektvirus
|
WO2011006214A1
(fr)
|
2009-07-16 |
2011-01-20 |
Peter Maccallum Cancer Institute |
Procédé de détection d'exposition à un rayonnement et de toxicité nocive de celle-ci
|
JP2013511988A
(ja)
|
2009-11-25 |
2013-04-11 |
ネステク ソシエテ アノニム |
過敏性腸症候群診断用の新規なゲノムバイオマーカー
|
WO2011084747A2
(fr)
|
2009-12-21 |
2011-07-14 |
The Johns Hopkins University |
Compositions et procédés pour des cellules souches pluripotentes induites de tissu somatique, provenant de l'endoderme
|
US20130029873A1
(en)
|
2010-04-12 |
2013-01-31 |
University Health Network |
Methods and compositions for diagnosing pulmonary fibrosis subtypes and assessing the risk of primary graft dysfunction after lung transplantation
|
WO2011128096A1
(fr)
|
2010-04-16 |
2011-10-20 |
Roche Diagnostics Gmbh |
Marqueurs de polymorphisme destinés à prédire la réponse à un traitement par un médicament anticorps monoclonal inhibant les récepteurs de l'interleukine-6
|
AU2011253481A1
(en)
|
2010-05-12 |
2013-01-10 |
Steven E. Schutzer |
Diagnostic markers for neuropsychiatric disease
|
US8945847B2
(en)
|
2010-05-24 |
2015-02-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for ascertaining biosafety of an agent
|
US20120058088A1
(en)
|
2010-06-28 |
2012-03-08 |
Resveratrol Partners, Llc |
Resveratrol-Containing Compositions And Methods Of Use
|
EP2593566B1
(fr)
|
2010-07-14 |
2018-01-24 |
The Regents of The University of California |
Biomarqueurs utilisés pour le diagnostic d'accidents ischémiques transitoires
|
US20140045915A1
(en)
|
2010-08-31 |
2014-02-13 |
The General Hospital Corporation |
Cancer-related biological materials in microvesicles
|
WO2012052953A1
(fr)
|
2010-10-20 |
2012-04-26 |
Fondazione Centro San Raffaele Del Monte Tabor |
Miarn
|
WO2012058097A1
(fr)
|
2010-10-26 |
2012-05-03 |
Buck Institute For Age Research |
Régulation à la baisse de la transcription du rétrotransposon sine/alu pour induire ou restaurer la capacité de prolifération et/ou la pluripotence d'une cellule souche
|
US9920317B2
(en)
|
2010-11-12 |
2018-03-20 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAs
|
JP6336755B2
(ja)
|
2010-11-12 |
2018-06-06 |
ザ ジェネラル ホスピタル コーポレイション |
ポリコームに関連する非コードrna
|
WO2012070014A2
(fr)
|
2010-11-26 |
2012-05-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Identification de nouveaux marqueurs de surface cellulaire pour des cellules progénitrices pancréatiques et des cellules endodermiques définies
|
EP2652149A2
(fr)
|
2010-12-16 |
2013-10-23 |
Norwegian University of Science and Technology (NTNU) |
Polymorphisme mononucléotidique associé au risque de développement d'une résistance à l'insuline
|
CA2822462A1
(fr)
|
2010-12-20 |
2012-06-28 |
The General Hospital Corporation |
Arn non codants associes a polycomb
|
WO2012151346A1
(fr)
|
2011-05-03 |
2012-11-08 |
Dermachip Inc. |
Signatures d'expression de gènes et réseaux de gènes associés au vieillissement de la peau
|
GB201112246D0
(en)
|
2011-07-15 |
2011-08-31 |
Univ Birmingham |
Diagnosis of alzheimer's disease
|
US20130079241A1
(en)
|
2011-09-15 |
2013-03-28 |
Jianhua Luo |
Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse
|
WO2013126565A1
(fr)
|
2012-02-24 |
2013-08-29 |
Lunyak Victoria V |
Régulation vers le bas de la transcription de sine/alu rétrotransposon pour induire ou restaurer la capacité proliférative et/ou la pluripotence dans une cellule souche
|
WO2013166264A2
(fr)
|
2012-05-02 |
2013-11-07 |
University Of Georgia Research Foundation, Inc. |
Procédés pour altérer la réplication de virus
|
WO2013177060A2
(fr)
|
2012-05-20 |
2013-11-28 |
Trustees Of Boston University |
Procédés et systèmes pour surveiller, diagnostiquer et traiter la maladie pulmonaire obstructive chronique
|
PT2800811T
(pt)
|
2012-05-25 |
2017-08-17 |
Univ California |
Métodos e composições para modificação de adn alvo dirigida por arn e para modulação dirigida por arn de transcrição
|
EP2864791A2
(fr)
|
2012-06-20 |
2015-04-29 |
Leibniz - Institut für Analytische Wissenschaften - ISAS - E.V. |
Biomarqueurs spécifiques pour un carcinome hépatocellulaire (hcc)
|
US20140004153A1
(en)
|
2012-07-02 |
2014-01-02 |
Lancell, L.L.C. |
Use of somatic mutations in the extracellular domain of transmembrane proteins in a patient's tumor as immunogens for active humoral immunotherapy of cancer
|
WO2014028946A2
(fr)
|
2012-08-17 |
2014-02-20 |
The Broad Institute, Inc. |
Modulateurs du métabolisme lipoprotéique hépatique
|
NZ706067A
(en)
|
2012-09-26 |
2016-07-29 |
Tangent Reprofiling Ltd |
Modulators of androgen synthesis
|
US9375433B2
(en)
|
2012-09-26 |
2016-06-28 |
Tangent Reprofiling Limited |
Modulators of androgen synthesis
|
HUE035887T2
(en)
|
2012-12-05 |
2018-05-28 |
Alnylam Pharmaceuticals Inc |
PCSK9 iRNA preparations and methods for their use
|
WO2014089486A1
(fr)
|
2012-12-07 |
2014-06-12 |
Shire Human Genetic Therapies, Inc. |
Nanoparticules lipidiques pour administration de marn
|
EP2971174A4
(fr)
|
2013-03-14 |
2017-06-14 |
Genomedx Biosciences Inc. |
Biomarqueurs et classificateurs de cancer et leurs utilisations
|
WO2014152940A1
(fr)
|
2013-03-14 |
2014-09-25 |
Shire Human Genetic Therapies, Inc. |
Compositions thérapeutiques à base d'arnm et leur utilisation pour traiter des maladies et des troubles
|
US20140378425A1
(en)
|
2013-03-15 |
2014-12-25 |
Veracyte, Inc. |
Biomarkers for diagnosis of lung diseases and methods of use thereof
|
US20140329704A1
(en)
|
2013-03-28 |
2014-11-06 |
President And Fellows Of Harvard College |
Markers for mature beta-cells and methods of using the same
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
US9574241B2
(en)
|
2013-06-03 |
2017-02-21 |
The Trustees Of Columbia University In The City Of New York |
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T-cell lymphomas
|
ES2677915T3
(es)
|
2013-06-03 |
2018-08-07 |
Nestec S.A. |
Método para diagnosticar valvulopatías crónicas
|
WO2014204728A1
(fr)
|
2013-06-17 |
2014-12-24 |
The Broad Institute Inc. |
Délivrance, modification et optimisation de systèmes, procédés et compositions pour cibler et modéliser des maladies et des troubles liés aux cellules post-mitotiques
|
RU2716420C2
(ru)
|
2013-06-17 |
2020-03-11 |
Те Брод Инститьют Инк. |
Доставка и применение систем crispr-cas, векторов и композиций для целенаправленного воздействия и терапии в печени
|
US20150079062A1
(en)
|
2013-07-12 |
2015-03-19 |
Patrick J. Casey |
Method for harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
|
WO2015008166A2
(fr)
|
2013-07-12 |
2015-01-22 |
Casey Patrick J |
Procédé de récolte, de traitement, et de stockage de protéines de l'unité foeto-placentaire de mammifères et utilisation de ces protéines dans des compositions et pour un traitement médical
|
RU2545990C2
(ru)
|
2013-07-16 |
2015-04-10 |
Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы |
Способ дифференциальной диагностики стеатоза печени и стеатогепатита
|
EA201690576A1
(ru)
|
2013-10-22 |
2016-10-31 |
Шир Хьюман Дженетик Терапис, Инк. |
Липидные композиции для доставки матричной рнк
|
CN103520724B
(zh)
|
2013-10-23 |
2016-05-25 |
江苏美迪森生物医药有限公司 |
Hsd17b13蛋白或其编码基因的抑制剂的新用途
|
GB201320061D0
(en)
|
2013-11-13 |
2013-12-25 |
Electrophoretics Ltd |
Materials nad methods for diagnosis and prognosis of liver cancer
|
CA2950800C
(fr)
|
2014-05-09 |
2023-01-10 |
Tangent Reprofiling Limited |
Modulateurs de la synthese des androgenes
|
CA2951707A1
(fr)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Procede d'edition genique
|
US10588980B2
(en)
|
2014-06-23 |
2020-03-17 |
Novartis Ag |
Fatty acids and their use in conjugation to biomolecules
|
WO2016004387A1
(fr)
|
2014-07-02 |
2016-01-07 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Signature d'expression génique utilisable à des fins de pronostic du cancer
|
EP3169339A1
(fr)
|
2014-07-14 |
2017-05-24 |
Patrick J. Casey |
Procédé de récolte, de traitement, et de stockage de protéines de l'unité foeto-placentaire de mammifère et utilisation de ces protéines dans des compositions et dans un traitement médical
|
WO2016028638A1
(fr)
|
2014-08-18 |
2016-02-25 |
Drexel University |
Procédés, supports lisibles par ordinateur et systèmes permettant d'évaluer des échantillons et des plaies, de prédire si une plaie va se cicatriser et de contrôler l'efficacité d'un traitement
|
WO2016073768A1
(fr)
|
2014-11-05 |
2016-05-12 |
Veracyte, Inc. |
Systèmes et procédés de diagnostic de la fibrose pulmonaire idiopathique sur des biopsies transbronchiques à l'aide de l'apprentissage automatique et de données de transcription dimensionnelle élevée
|
EP3256587A2
(fr)
|
2015-02-13 |
2017-12-20 |
Alnylam Pharmaceuticals, Inc. |
Compositions d'arni du gène codant pour la protéine 3 contenant un domaine phospholipase de type patatine (pnpla3) et leurs procédés d'utilisation
|
CN104698108B
(zh)
|
2015-03-26 |
2016-11-09 |
中国药科大学 |
一种利用固定化酶筛选I型17β羟类固醇脱氢酶抑制剂的方法
|
EP3350328A1
(fr)
|
2015-09-14 |
2018-07-25 |
Alnylam Pharmaceuticals, Inc. |
Agents de polynucléotide ciblant un domaine de phospholipase de type patatine contenant 3 (pnpla3) et leurs procédés d'utilisation
|
EP3159407A1
(fr)
|
2015-10-23 |
2017-04-26 |
Silence Therapeutics (London) Ltd |
Arn de guidage, procédés et utilisations
|
JP2018536689A
(ja)
|
2015-12-10 |
2018-12-13 |
アルナイラム ファーマシューティカルズ, インコーポレイテッドAlnylam Pharmaceuticals, Inc. |
ステロール調節エレメント結合タンパク質(SREBP)シャペロン(SCAP)iRNA組成物およびその使用方法
|
JP2019500345A
(ja)
|
2015-12-14 |
2019-01-10 |
コールド スプリング ハーバー ラボラトリー |
肝臓病の処置のための組成物および方法
|
JP7049247B2
(ja)
|
2015-12-14 |
2022-04-06 |
コールド スプリング ハーバー ラボラトリー |
腎臓病の処置のための組成物と方法
|
EP4104867A3
(fr)
|
2015-12-14 |
2023-03-01 |
Cold Spring Harbor Laboratory |
Compositions et méthodes pour le traitement de maladies du système nerveux central
|
EP3389671A4
(fr)
|
2015-12-14 |
2019-07-17 |
Cold Spring Harbor Laboratory |
Oligomères antisens pour le traitement du syndrome d'alagille
|
EP3390635A4
(fr)
|
2015-12-14 |
2019-05-01 |
Cold Spring Harbor Laboratory |
Oligomères antisens pour le traitement de la sclérose tubéreuse de bourneville
|
CA3005128A1
(fr)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Compositions et methodes pour le traitement de maladies oculaires
|
ES2903394T3
(es)
|
2015-12-14 |
2022-04-01 |
Cold Spring Harbor Laboratory |
Composiciones para el tratamiento de la retinitis pigmentosa 13
|
EP3426826A4
(fr)
|
2016-03-09 |
2019-09-04 |
Molecular Stethoscope, Inc. |
Procédés et systèmes destinés à la détection d'états de tissu
|
IL304057A
(en)
|
2016-03-16 |
2023-08-01 |
Spogen Biotech Inc |
Methods for promoting plant health using free enzymes and microorganisms that cause overexpression of enzymes
|
EP3452101A2
(fr)
|
2016-05-04 |
2019-03-13 |
CureVac AG |
Arn codant pour une protéine thérapeutique
|
US10036024B2
(en)
|
2016-06-03 |
2018-07-31 |
Purdue Research Foundation |
siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)
|
US10767175B2
(en)
|
2016-06-08 |
2020-09-08 |
Agilent Technologies, Inc. |
High specificity genome editing using chemically modified guide RNAs
|
GB201609977D0
(en)
|
2016-06-08 |
2016-07-20 |
Cancer Rec Tech Ltd |
Chemosensitivity predictive biomarkers
|
EA201991369A1
(ru)
|
2016-12-08 |
2019-12-30 |
Интеллиа Терапьютикс, Инк. |
Модифицированные направляющие рнк
|
US20180185516A1
(en)
|
2016-12-09 |
2018-07-05 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
KR20210035022A
(ko)
|
2016-12-14 |
2021-03-31 |
리간달 인코포레이티드 |
핵산 및/또는 단백질 적재물 전달을 위한 조성물 및 방법
|
KR102619197B1
(ko)
|
2017-01-23 |
2024-01-03 |
리제너론 파마슈티칼스 인코포레이티드 |
Hsd17b13 변종 및 이것의 용도
|
US20220090127A1
(en)
|
2017-06-02 |
2022-03-24 |
Institut National De La Sante Et De La Recherche Medicale (Inserm |
Viral vector combining gene therapy and genome editing approaches for gene therapy of genetic disorders
|
EP3695012B1
(fr)
*
|
2017-10-11 |
2023-03-08 |
Regeneron Pharmaceuticals, Inc. |
Inhibition de hsd17b13 dans le traitement de la maladie hépatique chez des patients exprimant la variation pnpla3 i148m
|
CN112020556A
(zh)
|
2018-03-21 |
2020-12-01 |
瑞泽恩制药公司 |
第13型17β羟基类固醇脱氢酶(HSD17B13)iRNA组成物及其使用方法
|
US20210000906A1
(en)
|
2018-03-21 |
2021-01-07 |
Ionis Pharmaceuticals, Inc. |
Modulation of hsd17b13 expression
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
CA3102950A1
(fr)
|
2018-06-08 |
2019-12-12 |
Intellia Therapeutics, Inc. |
Arn guides modifies pour edition de genes
|
AU2019288373A1
(en)
|
2018-06-19 |
2021-01-14 |
The Board Of Regents Of The University Of Texas System |
Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids
|
US11957687B2
(en)
|
2019-07-02 |
2024-04-16 |
Regeneron Pharmaceuticals, Inc. |
Modulators of HSD17B13 and methods of use thereof
|